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Background: Neurodevelopmental disorders are impairments of brain function that affect emotion, learning, and
memory. Copy number variations of contactin genes (CNTNs), including CNTN3, CNTN4, CNTN5, and CNTN6, have
been suggested to be associated with these disorders. However, phenotypes have been reported in only a handful
of patients with copy number variations involving CNTNs.
Methods: From January 2009 to January 2013, 3724 patients ascertained through the University of Pittsburgh
Medical Center were referred to our laboratory for clinical array comparative genomic hybridization testing. We
screened this cohort of patients to identify individuals with the 3p26.3 copy number variations involving the CNTN6
gene, and then retrospectively reviewed the clinical information and family history of these patients to determine
the association between the 3p26.3 copy number variations and neurodevelopmental disorders.
Results: Fourteen of the 3724 patients had 3p26.3 copy number variations involving the CNTN6 gene. Thirteen of the
14 patients with these CNTN6 copy number variations presented with various neurodevelopmental disorders including
developmental delay, autistic spectrum disorders, seizures and attention deficit hyperactivity disorder. Family history
was available for 13 of the 14 patients. Twelve of the thirteen families have multiple members with
neurodevelopmental and neuropsychiatric disorders including attention deficit hyperactivity disorder, seizures, autism
spectrum disorder, intellectual disability, schizophrenia, depression, anxiety, learning disability, and bipolar disorder.
Conclusions: Our findings suggest that deletion or duplication of the CNTN6 gene is associated with a wide spectrum
of neurodevelopmental behavioral disorders.
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Neuropsychiatric disordersBackground
Contactins (CNTNs) are members of a protein subfamily
of neural immunoglobulin (Ig) domain-containing cell
adhesion molecules, which may play a role in the forma-
tion of axon connections in the developing nervous
system. The CNTN4 and CNTN6 genes are located at* Correspondence: jhu@upmc.edu
1Pittsburgh Cytogenetics Laboratory, Center of Medical Genetics and
Genomics, Magee-Womens Hospital of UPMC, Pittsburgh, PA 15213, USA
2Department of Obstetrics, Gynecology & Reproductive Sciences, University
of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
Full list of author information is available at the end of the article
© 2015 Hu et al. Open Access This article is
International License (http://creativecommo
reproduction in any medium, provided you
link to the Creative Commons license, and
Dedication waiver (http://creativecommons
article, unless otherwise stated.the distal part of the short arm of chromosome 3
(3p26.3). The CNTN4 gene has been proposed as one of
the critical genes for chromosome 3pter-p25 deletion
syndrome [1]. The characteristic features associated with
this syndrome include prenatal and postnatal growth re-
tardation, developmental delay (DD), intellectual disabil-
ities (ID), hypotonia, and microcephaly (OMIM #613792).
Gene association studies have shown the involvement of
contactin genes (CNTNs) in autism spectrum disorders
(ASDs) [2, 3]. The disruption of a single copy of the
CNTN4 by a de novo balanced translocation has beendistributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
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drome including DD, mild ID, hypotonia, ptosis, and ASD
[4, 5]. In addition, chromosome 3 copy number variations
(CNVs) involving the CNTN4 gene have been reported to
be associated with ASD in a few patients without any
other classic 3p deletion syndrome phenotype in three
independent studies using genome-wide SNP genotyping
or microarray analysis [6–8]. The CNTN6 gene, which
encodes another member of the contactin family, mapped
just distal to the CNTN4 gene is also deleted in the 3p
deletion syndrome. A study by Cui et al. [9] shows that
the CNTN6 (NB-3) participates in the generation of oligo-
dendrocytes by acting as a ligand of NOTCH1 to promote
NOTCH1 activation through the released notch intracel-
lular domain (NICD) and subsequent translocation to the
nucleus. The expression of Cntn6 in the mouse brain is at a
low level during embryogenesis but increases significantly
after birth [10]. Northern blot analysis showed that the level
of CNTN6 expression in human adult brain was the highest
in the cerebellum, followed by the thalamus and subtha-
lamic nucleus, and was lower in the corpus callosum, caud-
ate nucleus, and spinal cord [11]. Moreover, studies have
shown that Cntn6−/− deficient mice have impaired motor
coordination and abnormal apical dendrite projections of
deep layer pyramidal neurons in the visual cortex [12, 13].
In addition, a recent study indicated that CNTN4, CNTN5,
and CNTN6 proteins may be a part of the heteromeric re-
ceptor complexes and serve as ligands themselves [14].
Therefore, deletion or duplication of the CNTN6 gene may
affect the function of the receptor complex and cause mal-
function of the brain and nervous system. These CNVs in-
volving the CNTN5 or CNTN6 gene alone have also been
reported in a handful of patients with either ASD or ID or
DD [15–18]. However, this remains controversial. A study
involving a single family concluded that the deletion of the
CNTN6 gene is not associated with dysmorphic features
and ID [19]. In this study, we report 3p26.3 CNVs encom-
passing the CNTN6 gene in 14 patients. Thirteen of the 14
patients have neurodevelopmental disorders (NDDs) and
seven of the 14 patients have dysmorphic features.
Methods
Patient ascertainment
From January 2009 to January 2013, 3724 patients ascer-
tained through the University of Pittsburgh Medical Cen-
ter (UPMC) were referred to our laboratory for clinical
array comparative genomic hybridization (aCGH) testing
because of the presence of multiple congenital anomalies,
heart defect, short stature, DD, ID, ASD, seizures (SZs),
or other unexplained anomalies. The clinical information
and family history of the patients with the 3p26.3 CNV
were retrospectively reviewed. This study was approved
by the University of Pittsburgh Institutional Review
Board (IRB#: PRO13090288).Array-based comparative genomic hybridization analysis
Oligonucleotide-based whole-genome aCGH was per-
formed using a NimbleGen 135K oligonucleotide array,
SignatureChip Oligo Solution version 2.0, which was
custom-designed by Signature Genomic Laboratories
(Spokane, WA, USA) and made by Roche NimbleGen
(Madison, WI, USA) as previously described [20]. Results
were displayed by custom aCGH analysis software Geno-
glyphix version 2.6 (Signature Genomic Laboratories).
Chromosome analysis
High-resolution G-banded chromosome analysis was
performed on the peripheral blood specimen following
routine protocols. A minimum of 20 metaphase cells were
examined for both numerical and structural chromosomal
anomalies, and two or more karyograms were created
using the Ikaros Karyotyping System (MetaSystems,
Waltham, MA, USA) on each patient.
Fluorescence in situ hybridization analysis
Fluorescence in situ hybridization (FISH) analysis was
performed on metaphase spreads of cultured peripheral
blood lymphocytes from patients and their parents using
standard procedures. FISH probes were made from the
RPCI-11 human genomic library (Invitrogen, Carlsbad,
CA, USA) using Nick Translation Kit (Abbott Molecular
Inc., Des Plaines, IL, USA). Images were captured using
the Isis FISH Imaging System v5.3 software (MetaSystems,
Waltham, MA, USA).
Results
Fourteen of the 3724 patients (0.4 %) were found to have
CNVs involving the CNTN6 gene. Seven of the 14 pa-
tients had single copy loss in the 3p26.3 region involving
deletion of the entire CNTN6 gene (patients 1 and 2) or
intragenic CNTN6 deletion (patients 3–7). Five of the 14
patients had a single copy gain in the 3p26.3 region
involving an intragenic duplication of the CNTN6 gene
(patients 8–12). The remaining two patients (patients 13
and 14) had duplications encompassing CHL1/CNTN6
and CHL1/CNTN6/CNTN4 genes, respectively. The rep-
resentative aCGH profiles (patient 2 and patient 9) are
shown in Fig. 1a, b. The schematic representation of the
array-CGH results in 14 patients is shown in Fig. 2. The
size of the deletions/duplications involving the CNTN6
gene alone ranged from 93.95 kb to 1.23 Mb. No other
known pathogenic CNVs or CNVs with unclear clinical
significance were observed in any of these patients. The
laboratory and clinical findings of these patients and
their family histories are summarized in Tables 1 and 2.
The genomic positions of the deletion or the duplication
for each patient are illustrated in Fig. 2 and summarized
in Tables 1 and 2. The karyotype was normal in all 14
patients. Parental FISH analysis was offered to the
a.  Chr3
b.  Chr3
Fig. 1 a aCGH profile showing an approximately 821-kb deletion in the 3p26.3 region (1,063,289–1,884,842) detected in patient 2; genome
browser [hg18] showing the CNTN6 in the deleted region. b aCGH profile showing an approximately 541-kb duplication in the 3p26.3 region
(855,662–1,397,384) detected in patient 9; genome browser [hg18] showing CNTN6 in the duplicated region
Hu et al. Journal of Neurodevelopmental Disorders  (2015) 7:26 Page 3 of 9families. However, only four families completed the FISH
testing (family 6, 8, 11, and 13). The results of the parental
FISH analysis indicated that these CNVs are inherited.
Thirteen of the 14 patients with these CNVs presented
with variable clinical manifestation of neurodevelopmental
disorders including ASD in three patients (patients 1, 4,
and 11), DD in 10 patients (patients 1–5, 8–11, and 14),
SZs in seven patients (patients 2, 3, 5, 6, 8, 11, and 14),
and ADHD in four patients (patients 8, 11, 13 and 14).
The remaining patient with intragenic deletion of the
CNTN6 was a newborn whose development and behavior
at 1 year of age was normal. He was tested because of
heart block. In addition, two patients had macrocephaly
(patients 2 and 8), one had hydrocephaly (patient 5), and
one had microcephaly (patient 10). Other malformations/
dysmorphisms were also found in six of the 14 patients,
which include craniofacial abnormalities (asymmetric
face: patient 14; high-arched palate: patients 2 and 14;
schizencephaly: patient 5; brachycephaly: patient 11),
digital anomalies (second and third toe syndactyly: patient10; unusual large hallux and short second toe: patient 11;
fifth finger clinodactyly: patient 14), and eye problems
(nystagmus: patient 2; esotropia: patient 14; strabismus:
patient 3). Family history was available for 13 of the 14
patients, except patient 5 who was adopted. Family 7 had
maternal family history of Sjogren’s syndrome. The re-
maining 12 families had multiple members with NDDs
and neuropsychiatric disorders including ADHD, SZs,
ASD, ID, schizophrenia, depression, anxiety, learning dis-
ability, and bipolar disorder. The pedigree for each family
is presented in Fig. 3, and only neurodevelopmental or
psychiatric issues are marked in these pedigrees. More de-
tailed family information is summarized in Tables 1 and 2.
Discussion
Deletions of both CNTN4 and CNTN6 genes have been
reported in the 3p deletion syndrome, which is charac-
terized by low birth weight, growth restriction, DD, ID,
hypotonia, and microcephaly. We present here 13 of the
14 patients with neurodevelopmental disorders and
Fig. 2 Schematic representation of the array-CGH results of the 14 patients with deletion or duplication of the 3p26.3 region. The ideogram of
chromosome 3 and the 3p26.3 highlighted in a small red box is shown on top. The red bars represent deletion sizes, and the blue bars represent
duplication sizes. The genes in the interval are shown at the bottom
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gene. The clinical features include ASD, DD, SZs, and
ADHD. These CNVs involving the CNTN6 gene or
CNTN6 and CHL1 genes have been reported in five pa-
tients in three previous independent studies [15–18]. The
clinical findings are consistent with the features in our pa-
tients. Moreover, macrocephaly presented in two of the 14
patients has been reported in patients with ASD, while
microcephaly presented in one of the 14 patients has been
reported in chromosome 3p deletion syndrome [21, 22].
Furthermore, microcephaly was also reported in two previ-
ously reported patients with deletion of CNTN6 [16]. In
addition to microcephaly, other manifestations of chromo-
some 3pter-p25 deletion syndrome also exist in one or two
of our patients, such as high-arched palate, second and
third toe syndactyly, fifth finger clinodactyly, ptosis, joint
laxity. and scoliosis (Tables 1 and 2). Syndactyly, clinodac-
tyly and scoliosis, joint laxity and high arched palate were
previously reported in patients who have the CNTN6 dele-
tions [16, 18]. Since the genomic location of the CNTN6
gene is within the deletion interval for chromosome 3pter-
p25 deletion syndrome, losses of the CNTN6 gene may
contribute to the phenotype observed in chromosome
3pter-p25 deletion syndrome. In addition, among the eight
patients with gain of copy number in this region five of
them had CNV involving partial duplication of the CNTN6
gene. It is unclear whether the expression of CNTN6 gene
has been altered in these patients as there is a lack of pub-
lished functional studies of these CNVs. However, partialduplications of other gene, such as partial duplications of
the CHRNA7 gene, have shown to alter the function of the
gene product by dominant negative regulation [23]. Unlike
3p terminal deletions which are often de novo events, these
CNTN6 deletions or duplications reported previously and
found in our patients are interstitial and are more likely
inherited. These deletions and duplications vary in size and
in location of breakpoints. The lack of segmental duplica-
tions in the surrounding sequences suggests that nonallelic
homologous recombination is not the mechanism under-
lying these deletion and duplication events.
It is striking that 12 of the 13 families have positive family
history of various NDDs and neuropsychiatric disorders in-
cluding ADHD, SZs, ASD, ID, schizophrenia, depression,
anxiety, learning disability, and bipolar disorder (Fig. 3;
Tables 1 and 2). It is known that the NDDs and psychiatric
disorders appear to present a disease spectrum and the out-
come of the neurodevelopmental process in each individual
patient is determined by interactions among genetic, socio-
cultural, medical, and environmental factors. Therefore,
intrafamilial and interfamilial phenotypic heterogeneity and
possible incomplete penetrance are expected. Individual
and familial comorbidity among SZs, ASD, bipolar disorder,
major depression, ADHD, and other psychiatric diagnoses
have been documented by large-scale epidemiological stud-
ies [24–27]. These studies suggest a possible genetic overlap
between these disorders, which could attribute to the famil-
ial vulnerability to NDDs and psychiatric disorders [28].
Risk loci shared by major psychiatric disorders have been
Table 1 Laboratory findings, clinical features, and family histories of seven patients with 3p26.3 deletion involving CNTN6 gene
Patients Age
(year)
CNV sizes Coordinates
(hg18)
Inheritance OMIM
genes
Types of
deletion
Reasons
for referral
Other features Family history of NDDs and/or
neuropsychiatric disorders
1 5 1.23 Mb 535,618–1,763,192 Unknown CNTN6 Whole
gene
ASD, DD Tantrums, aggression Father: LD; mother: SZs,
hearing loss, and mental health
issue
2 3 821.55 kb 1,063,289–1,88,4842 Unknown CNTN6 Whole
gene
DD, SZs Nystagmus,
macrocephaly, frontal
bossing, down-slanting
palpebral fissures,
high-arched palate
Paternal aunt: ID; maternal
aunt, cousin, grandmother,
and grandaunt: SZs
3 11 93.95 kb 1,124,286–1,218,241 Unknown CNTN6 Exon 2 DD, SZs, ID Strabismus, regression
in skills, headache
Father: LD; mother: SZs,
schizophrenia, migraines;
multiple members of maternal
side: LD, ASD, SZs, depression,
anxiety, bipolar disorder,
schizophrenia
4 6 106.77 kb 1,227,323–1,334,091 Unknown CNTN6 Exons
3–7
DD, ASD Tantrums Maternal grandmother:
depression
5 2 115.87 kb 1,266,963–1,382,828 Unknown CNTN6 Exons
5–12
DD, SZs Schizencephaly,
hydrocephaly,
hydronephrosis,
diabetes insipidus,
hypothyroidism,
right-sided spasticity
and hemiparesis,
cardiomyopathy
Adopted into family; adopted
sibling: schizophrenia
6 6 125.24 kb 1,322,292–1,447,530 Paternally
inherited
CNTN6 Exons
8–23
SZs Abnormal EEG Father: del. CNTN6, normal
phenotype; sister: del. CNTN6,
SZs; mother and brother:
without del. CNTN6,
phenotypically normal; a
maternal aunt: SZs
7 1 244 kb 1,124,286–1,419,226 Unknown CNTN6 Exons
2–23
Heart
block
No No
ASD autism spectrum disorder, CNV copy number variation, del. deletion, DD developmental delay, EEG electroencephalogram, ID intellectual disability, LD learning
disability, NDD neurodevelopmental disorder, SZs seizures
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developmental genes have been found to predispose to a
wide spectrum of developmental or psychiatric disorders
[30–33]. Similar to other CNVs involving synaptic and neu-
rodevelopmental genes, the CNVs disrupting the CNTN6/
CNTN4 region have also been reported in patients with
intellectual disabilities, cognitive disorders, severe anorexia
nervosa, and bipolar disorder in addition to ASD
[16, 19, 26, 34]. These published records support our
hypothesis of variable expression of the CNVs involv-
ing the CNTN6 gene.
Most of the families in our study presented with NDDs
and/or psychiatric disorders in both maternal and paternal
sides, which makes it difficult to determine the segregation
patterns of these CNVs. In family 13, the asymptomatic
father has normal copy number for CNTN6; the proband
with ADHD and bipolar disorder inherited the duplication
of CNTN6 from the mother who has psychiatric problems.
In addition, the proband’s maternal half sister has ADHD,
and twin brother and full sister have bipolar disorder. How-
ever, the copy number for CNTN6 in these individuals wasnot determined. In family 6, the proband and her sister with
seizures have a paternally inherited deletion of CNTN6, and
her phenotypically normal mother and brother have normal
copy number of CNTN6. Although the father of the pro-
band 6 is an asymptomatic carrier of the deletion, it may in-
dicate an incomplete penetrance. Incomplete penetrance
was also observed in family 8 (Fig. 3) and in previously re-
ported families [15, 16, 19]. Parental FISH analysis and fam-
ily history in families 13 and 6 may suggest that the CNVs
segregate with the abnormal phenotypes. However, more
extended family studies are needed for segregation analysis
in the future. Furthermore, most patients have both mater-
nal and paternal family histories of NDDs and/or psychi-
atric disorders. Therefore, the possibility of a double hit
model for inheritance also exists. Based on our study, the
CNTN6 CNVs are rare and presented in about 4 out of
1,000 (14/3,724) patients. At least 40 patients with similar
small duplication or deletion involving CNTN6 gene or
CNTN6 and CNTN4 genes are reported in the DECIPHER
database. These CNVs have also been reported in some
phenotypically normal individuals [35]. An expanded CNV
Table 2 Laboratory findings, clinical features, and family histories of seven patients with 3p26.3 duplication involving CNTN6 gene
Patients Age
(year)
CNV sizes Coordinates (hg18) Inheritance OMIM
genes
Types of
deletion
Reasons
for referral
Other features Family history of NDDs
and/or neuropsychiatric
disorders
8 7 718.82 kb 476,636–1,195,459 Maternally
inherited
CNTN6 Upstream
and exons
1–2
DD, SZs ADHD, DBD, abnormal
EEG, macrocephaly,
epicanthal folds, high
and wide nasal bridge,
broad nasal tip, large
central incisors
Mother: normal
phenotype; father:
schizophrenia, alcoholic;
sister: DD; maternal half
brother: ADHD, hearing
loss, anxiety
9 8 541.62 kb 855,662–1,397,284 Unknown CNTN6 Upstream
and exons
1–17
DD Short stature, reflux Father: depression;
mother: ADHD, anxiety
10 6 199.60 kb 1,124,286–1,323,884 Unknown CNTN6 Exons 2–7 DD Short stature, reflux,
joint hypermobility,
microcephaly, low
anterior hairline, second
and third toe syndactyly
A sister: ASD,
microcephaly; another
sister: microcephaly;
brother: ASD; paternal
half brother: ADHD; both
parents: microcephaly;
paternal grandmother:
seizures
11 7 489.60 kb 1,172622–1,662,216 Paternally
inherited
CNTN6 Exons
3–23 and
downstream
DD, ASD,
SZs
LD, ADHD, ODD, VSD,
feeding difficulties,
failure to thrive,
brachycephaly, upswept
anterior hairline, unusual
large hallux, and short
second toe
Father: bipolar disorder
and ADHD; brother:
ADHD, ODD; paternal
twin half sisters: DD;
mother: bipolar
disorder, migraines;
maternal grandaunt:
migraine
12 9 281 kb 1,189,367–1,470,327 Unknown CNTN6 Exons
4–23 and
downstream
LD No Father: ID, ADHD,
bipolar disorder,
depression; mother:
bipolar disorder,
depression; sibling:
LD; sister: ID
13 15 886.76 kb 243,741–1,130,505 Maternally
inherited
CHL1,
CNTN6
Whole CHL1
and exons 1
of CNTN6
Obesity,
ADHD,
bipolar
OCD, migraine,
scoliosis, fibromyalgia,
rheumatoid arthritis,
asthma, irritable bowel
syndrome
Mother: migraines,
fibromyalgia, psychiatric
problem; twin brother
and sister: bipolar
disorder; maternal half
sister: ADHD, psychiatric
problems; paternal
grandmother: migraines
14 16 2.05 Mb 413,294–2,465,270 Unknown CHL1,
CNTN6,
CNTN4
Exons 23–25
of CHL1,
CNTN6 and
exons 1–2
of CNTN4
DD, SZs,
dysmorphic
ADHD, OCD,
sensorineural hearing
loss, asymmetric face,
left esotropia, bilateral
ptosis, high-arched
palate, short stature,
single palmar creases,
fifth finger clinodactyly,
cranial nerve palsy,
micropenis
Father: depression;
paternal cousin: ASD
ADHD attention deficit hyperactivity disorder, ASD autism spectrum disorder, CNV copy number variation, DBD disruptive behavior disorders, DD developmental
delay, dup duplication, EEG electroencephalography, ID intellectual disability, LD learning disability, NDD neurodevelopmental disorder, OCD, obsessive–compulsive
disorder, ODD oppositional defiant disorder, VSD ventricular septal defect, SZs seizures
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opmental delay in comparison to 19,584 healthy controls
by Coe et al. [35] showed a frequency of 0.4 % for CNTN6
CNVs (deletion and duplication) in patients with neurode-
velopmental disorders and a frequency of 0.3 % in normal
controls. Incomplete penetrance and variable expression
are common in neurodevelopmental and neurologicaldisorders. Some patients with these CNVs could have mild
or normal phenotype. Therefore, these CNVs can be de-
tected in “healthy individuals.” Finding of the CNVs involv-
ing CNTN6 gene in normal individuals does not exclude
the possibility that these CNVs are risk factors for NDDs.
Individuals having a mild phenotype may not be
recognized.
Family 1 (del) Family 3 (del) Family 4 (del) Family 7 (dup)Family 5 (del)
Family 6 (del, pat)
hearing loss
mental health issues
* nystagmus
macrocephaly
tantrums
aggression
tantrums
pat pat
migraine
Family 2 (del)
anxiety
*
Family 9 (dup)
multiple members with 
LD, ASD, Seizures, 
depression, anxiety, 
bipolar, schizophrenia
*hydrocephaly
34
* mat 
OCD, migraine
fibromyalgia
psychiatric 
problems
OCD
Hearing loss
Family 12 (dup)
Family 11 (dup, pat) 
*ODD
microcephaly   microcephaly microcephaly
*
macrocephaly; disruptive 
behavior disorders
Family 10 (dup)
migraine
fibromyalgia
psychiatric problem
* migraine
*
Family 13 (dup, mat)
migraine
*
*migraine
domestic violence, drug 
and alcohol abuse*
*additional features that may be related to the neurodevelopmental or psychiatric issue;  ASD: autism spectrum disorder; mat: maternally 
inherited; pat: paternally inherited ; del: deletion; dup: duplication; DD: developmental delay; ID: intellectual disability; LD: learning disability; 
OCD: Obsessive–compulsive disorder ; ODD: oppositional defiant disorder;        : FISH with deletion;        : FISH with duplication;        : FISH 
with normal copy number
microcephaly
microcephaly 
**
* * *
* hearing loss
anxiety
mat*
alcohol abuse *
mental 
health issues *
hallucinations
*
5
Family 8 (dup, mat)
*
anxiety
*
Family 14 (dup)
Fig. 3 Pedigrees of the 14 families
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involving duplications of CHL1 and CNTN6 or CHL1,
CNTN6, and CNTN 4 genes, respectively. Both patients
13 and 14 have DD, ADHD, oppositional defiant disorder
(ODD) and dysmorphic features. In addition, patient 13
has bipolar disorder. Both CHL1 and CNTN4 are
expressed in the brain and have been proposed as candi-
date genes for NDDs [1, 36]. Patient 14 has more dys-
morphic features including short stature, high-arched
palate, bilateral ptosis, clinodactyly, and micropenis, which
are commonly present in patient with chromosome 3pter-
p25 deletion syndrome. Our study and previous studies
found dysmorphic features are also commonly seen in
patients who have the CNV involving CNTN6 gene only
[16, 18]. These findings indicate that dosage alterations of
CNTN genes may affect the normal development of other
tissues or organs in addition to the brain.
Conclusions
We identified 3p26 CNVs involving the deletion/intra-
genic deletion or duplication/intragenic duplication of
CNTN6 gene in 14 patients. Twelve of the 14 patients
have the CNV encompassing CNTN6 gene alone. Thirteen
of the 14 patients have neurodevelopmental behavioral
disorders and remarkable family history for neurodevelop-
ment or neuropsychiatric disorders. Seven of the 14 pa-
tients presented with dysmorphic features. Our findings
provide more evidence to support that deletion or duplica-
tion of the CNTN6 gene is associated with a wide spectrum
of neurodevelopmental behavioral disorders. These geno-
type phenotype correlations pave the way to further investi-
gate the role of CNTN6 in neurodevelopmental disorders.
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